First Trust Nasdaq Pharmaceuticals ETF (FTXH)
FTXH is a passive ETF by First Trust tracking the investment results of the Nasdaq U.S. Smart Pharmaceuticals Index. FTXH launched on Sep 20, 2016 and has a 0.60% expense ratio.
ETF Info
ISIN | US33738R8372 |
---|---|
CUSIP | 33738R837 |
Issuer | First Trust |
Inception Date | Sep 20, 2016 |
Region | North America (U.S.) |
Category | Health & Biotech Equities |
Index Tracked | Nasdaq U.S. Smart Pharmaceuticals Index |
Home Page | www.ftportfolios.com |
Asset Class | Equity |
Asset Class Size | Multi-Cap |
Asset Class Style | Blend |
Expense Ratio
The First Trust Nasdaq Pharmaceuticals ETF has a high expense ratio of 0.60%, indicating higher-than-average management fees.
Share Price Chart
Loading data...
Compare to other instruments
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in First Trust Nasdaq Pharmaceuticals ETF, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
First Trust Nasdaq Pharmaceuticals ETF had a return of 5.49% year-to-date (YTD) and 10.42% in the last 12 months.
Period | Return | Benchmark |
---|---|---|
Year-To-Date | 5.49% | 10.16% |
1 month | -0.93% | 3.47% |
6 months | 9.59% | 22.20% |
1 year | 10.42% | 30.45% |
5 years (annualized) | 6.79% | 13.16% |
10 years (annualized) | N/A | 10.89% |
Monthly Returns Heatmap
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2024 | 1.33% | 2.82% | ||||||||||
2023 | 1.26% | -4.58% | -5.97% | 3.91% | 7.05% |
Risk-Adjusted Performance
Risk-Adjusted Performance Indicators
This table presents risk-adjusted performance metrics for First Trust Nasdaq Pharmaceuticals ETF (FTXH) and compares them with a selected benchmark (^GSPC). These performance indicators assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Sharpe ratio | Sortino ratio | Omega ratio | Calmar ratio | Ulcer Index | |
---|---|---|---|---|---|
First Trust Nasdaq Pharmaceuticals ETF | 0.88 | ||||
S&P 500 | 2.79 |
Dividends
Dividend History
First Trust Nasdaq Pharmaceuticals ETF granted a 1.36% dividend yield in the last twelve months. The annual payout for that period amounted to $0.38 per share.
Period | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
---|---|---|---|---|---|---|---|---|---|
Dividend | $0.38 | $0.41 | $0.30 | $0.28 | $0.21 | $0.16 | $0.18 | $0.47 | $0.03 |
Dividend yield | 1.36% | 1.55% | 1.11% | 1.03% | 0.82% | 0.67% | 0.91% | 2.18% | 0.16% |
Monthly Dividends
The table displays the monthly dividend distributions for First Trust Nasdaq Pharmaceuticals ETF. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2024 | $0.00 | $0.00 | ||||||||||
2023 | $0.00 | $0.00 | $0.10 | $0.00 | $0.00 | $0.12 | $0.00 | $0.00 | $0.07 | $0.00 | $0.00 | $0.12 |
2022 | $0.00 | $0.00 | $0.05 | $0.00 | $0.00 | $0.04 | $0.00 | $0.00 | $0.09 | $0.00 | $0.00 | $0.13 |
2021 | $0.00 | $0.00 | $0.08 | $0.00 | $0.00 | $0.05 | $0.00 | $0.00 | $0.04 | $0.00 | $0.00 | $0.11 |
2020 | $0.00 | $0.00 | $0.06 | $0.00 | $0.00 | $0.05 | $0.00 | $0.00 | $0.04 | $0.00 | $0.00 | $0.06 |
2019 | $0.00 | $0.00 | $0.03 | $0.00 | $0.00 | $0.04 | $0.00 | $0.00 | $0.05 | $0.00 | $0.00 | $0.04 |
2018 | $0.00 | $0.00 | $0.08 | $0.00 | $0.00 | $0.04 | $0.00 | $0.00 | $0.03 | $0.00 | $0.00 | $0.04 |
2017 | $0.00 | $0.00 | $0.03 | $0.00 | $0.00 | $0.06 | $0.00 | $0.00 | $0.38 | $0.00 | $0.00 | $0.00 |
2016 | $0.03 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the First Trust Nasdaq Pharmaceuticals ETF. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the First Trust Nasdaq Pharmaceuticals ETF was 32.11%, occurring on Mar 23, 2020. Recovery took 82 trading sessions.
The current First Trust Nasdaq Pharmaceuticals ETF drawdown is 0.93%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
---|---|---|---|---|---|---|
-32.11% | Jan 17, 2020 | 45 | Mar 23, 2020 | 82 | Jul 20, 2020 | 127 |
-23.42% | Aug 29, 2018 | 76 | Dec 24, 2018 | 254 | Jan 14, 2020 | 330 |
-14.62% | Jan 30, 2018 | 59 | May 3, 2018 | 53 | Aug 7, 2018 | 112 |
-14.58% | Dec 5, 2022 | 226 | Oct 27, 2023 | 79 | Feb 22, 2024 | 305 |
-14.29% | Apr 11, 2022 | 117 | Sep 27, 2022 | 45 | Nov 30, 2022 | 162 |
Volatility
Volatility Chart
The current First Trust Nasdaq Pharmaceuticals ETF volatility is 3.16%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.